Yaqrit Ltd: Clinical Trials

5 trials sponsored by Yaqrit Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 terminated, 1 withdrawn. 4 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 21Recruiting 1

Follow Yaqrit Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.
Standard of Care (Investigator Choice), DIALIVE 2.0 liver dialysis Device plus available Standard of Care - Acute-on-Chronic Liver Failure (ACLF), Liver Cirrhosis
Not applicableRecruitingYaqrit Ltd722026-10-012026-09-22
A-TANGO Phase 2 Study
Placebo, TAK-242, G-CSF (Filgrastim) - Acute-On-Chronic Liver Failure, Alcoholic Hepatitis
Phase 2RecruitingYaqrit Ltd782026-06-292026-09-21
Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis
Yaq-001, Placebo - Non-Alcoholic Steatohepatitis
Not applicableWithdrawnYaqrit Ltd2021-01-312022-03-03
Safety and Tolerability of Yaq-001 in Patients With Cirrhosis
4g Yaq-001, 4g Placebo, 8g Yaq-001 - Liver Cirrhosis
Not applicableTerminatedYaqrit Ltd312019-02-282020-08-25
Safety and Performance Trial of DIALIVE Liver Dialysis Device in Acute On Chronic Liver Failure Patients
DIALIVE Liver Dialysis Device - Acute on Chronic Liver Failure
Not applicableCompletedYaqrit Ltd302017-07-092021-06-01

Conditions studied

Acute-On-Chronic Liver Failure (3)  ·  Liver Cirrhosis (2)  ·  Hepatitis, Alcoholic (1)  ·  Liver Cirrhosis, Alcoholic (1)  ·  Liver Diseases (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Interventions

Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Standard of Care (1)  ·  ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate (1)

Countries

United Kingdom (5)  ·  France (3)  ·  Spain (3)  ·  Italy (2)  ·  Portugal (2)  ·  Switzerland (2)  ·  Austria (1)  ·  Belgium (1)  ·  Denmark (1)  ·  Germany (1)  ·  Romania (1)

Top investigators

Jane Macnaughtan (2)  ·  Rajiv Jalan (2)  ·  Banwari Agarwal, Dr (1)

Results publications

PMID 37268222, PMID 38621924